Prognostic model for aggressive non-Hodgkin lymphoma.

被引：0
|
作者：
Genadieva-Stavrik, SG
Ivkovsi, LG
Zografski, GD
Georgievski, BA
Stojanoski, ZR
Pivkova, AT
Cevreska, LA
机构：
[1] Fac Med, Ctr Clin, Inst Radiotherapy & Oncol, Skopje, Macedonia
[2] Fac Med, Ctr Clin, Dept Hematol, Skopje, Macedonia
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4689.4689
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4689
引用
收藏
页码：252B / 252B
页数：1
相关论文
共 50 条
  • [1] Prognostic factors in aggressive primary gastrointestinal non-Hodgkin's lymphoma.
    Ryu, MH
    Huh, J
    Heo, DS
    Ryoo, BY
    Song, HS
    Kim, HJ
    Eo, WK
    Chung, JS
    Bang, SM
    Kang, YK
    BLOOD, 2002, 100 (11) : 295B - 295B
  • [2] Aggressive therapy for leptomeningeal involvement in Non-Hodgkin's Lymphoma.
    Ginzburg, AZ
    Buckstein, R
    Imrie, KR
    BLOOD, 2002, 100 (11) : 571A - 571A
  • [3] Prognostic model for aggressive non-Hodgkin lymphoma (single center experience)
    Genadieva-Stavrik, Sonja G.
    Georgievski, Borce A.
    Karanfilski, Oliver B.
    Siljanosvki, Nikola
    Stojanovik, Aleksandar
    Stojanoski, Zlate R.
    Pivkova, Aleksandra
    Sotirova, Tanja
    Cevreska, Lidija
    ANNALS OF ONCOLOGY, 2006, 17 : 203 - 203
  • [4] Treatment of elderly patients with aggressive non-Hodgkin's lymphoma.
    Paccalin, M
    Lacotte-Thierry, L
    Delwail, V
    REVUE DE MEDECINE INTERNE, 2002, 23 (07): : 632 - 637
  • [5] The prognostic value of body mass index in Hodgkin lymphoma and diffuse non-Hodgkin lymphoma.
    Turgut, Mehmet
    Kelkitli, Engin
    Atay, Memis Hilmi
    Cilingir, Fatih Mehmet
    Yilmaz, Bahiddin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Impact of absolute lymphocyte count on prognosis of aggressive non-Hodgkin lymphoma.
    Kaur, Anahat
    Grover, Punita
    Bulchandani, Sheetal
    Odeny, Thomas A.
    Madhusudhana, Sheshadri
    Shrestha, Anuj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Prognostic factors in localized aggressive non-Hodgkin's lymphoma
    Alici, S
    Bavbek, SE
    Kaytan, E
    Eralp, Y
    Onat, H
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 1 - 5
  • [8] Prognostic value of cytogenetic abnormalities in patients with non-Hodgkin's lymphoma.
    Juneja, S
    Matthews, J
    Lukeis, R
    Laidlaw, C
    Cooper, I
    Wolf, M
    Ironside, P
    Garson, OM
    BLOOD, 1995, 86 (10) : 2115 - 2115
  • [9] Dose intensity as a treatment related variable in aggressive non-Hodgkin's lymphoma.
    Rodriguez, J
    Romaguera, J
    McLaughlin, P
    Hagemeister, F
    Rodriguez, M
    Cabanillas, F
    BLOOD, 1997, 90 (10) : 3947 - 3947
  • [10] Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma
    Ziepert, M.
    Schmits, R.
    Trumper, L.
    Pfreundschuh, M.
    Loeffler, M.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 752 - 762
12345